@inbook{c4209a8fd5bf46d29900666e7afcd88b,
title = "Stereotactic body radiotherapy with functional treatment planning in hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer-related death in the United States, and considered an aggressive tumor with mean survival estimated between 6 and 20 months (El-Serag, NEJM 365:1118–1127, 2011). The choice of curative liver resection is limited by the presence of hepatic cirrhosis in 90% of patients, and the most appropriate therapy for HCC has historically been hepatic transplantation with 5-year survival rate of up to 85%. However, only 10% of patients are eligible for surgery (Fortune et al., J Clin Gastroenterol 47:S37–S42, 2013). We discuss functional treatment planning for patients with hepatic cirrhosis and HCC and present an argument in favor of liver SBRT as a viable option.",
author = "Alexander Kirichenko and Koay, {Eugene J.} and Shaakir Hasan and Christopher Crane",
year = "2018",
month = jan,
day = "1",
doi = "10.1007/174_2017_42",
language = "English (US)",
series = "Medical Radiology",
publisher = "Springer-Verlag",
pages = "203--210",
booktitle = "Medical Radiology",
}